Proteolysis in skeletal muscle and whole body in response to euglycemic hyperinsulinemia in normal adults

Scott Denne, E. A. Liechty, Y. M. Liu, G. Brechtel, A. D. Baron

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

To simultaneously assess the relative antiproteolytic effect of insulin on both skeletal muscle and in the whole body, phenylalanine rates of appearance (R(a); reflecting proteolysis) were measured across the leg (reflecting skeletal muscle) and in the whole body, utilizing a constant tracer infusion of [2H5]phenylalanine in the basal state and during euglycemic hyperinsulinemia (2,600 μU/ml) in seven normal adults. Phenylalanine R(a) in the leg was significantly decreased during hyperinsulinemia (6.11 ± 0.83 vs. 3.59 ± 0.70 μmol/min, P < 0.001). In contrast, leg phenylalanine rate of utilization (R(d)) was not significantly changed (4.88 ± 0.77 vs. 3.86 ± 0.92 μmol/min). Phenylalanine R(a) in the whole body was significantly decreased during hyperinsulinemia (49.4 ± 2.2 vs. 41.9 ± 2.3 μmol/min, P < 0.001). However, phenylalanine release was suppressed to a significantly greater degree in the leg than in the whole body during hyperinsulinemia (43 ± 7 vs. 15 ± 2%, P < 0.01). These results suggest that insulin suppresses proteolysis in the whole body and in skeletal muscle, even in the face of hypoaminoacidemia. In addition, the substantially greater degree of suppression of proteolysis by insulin in skeletal muscle compared with the whole body suggests that, at least under these conditions, insulin may have a greater antiproteolytic effect on skeletal muscle compared with other tissues.

Original languageEnglish
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume261
Issue number6 24-6
StatePublished - 1991
Externally publishedYes

Fingerprint

Proteolysis
Hyperinsulinism
Phenylalanine
Muscle
Skeletal Muscle
Leg
Insulin
Tissue

Keywords

  • Insulin
  • Phenylalanine
  • Protein turnover
  • Stable isotope tracers

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology

Cite this

Proteolysis in skeletal muscle and whole body in response to euglycemic hyperinsulinemia in normal adults. / Denne, Scott; Liechty, E. A.; Liu, Y. M.; Brechtel, G.; Baron, A. D.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 261, No. 6 24-6, 1991.

Research output: Contribution to journalArticle

@article{8267c2c46f85475a8c9cd7a88cb41a00,
title = "Proteolysis in skeletal muscle and whole body in response to euglycemic hyperinsulinemia in normal adults",
abstract = "To simultaneously assess the relative antiproteolytic effect of insulin on both skeletal muscle and in the whole body, phenylalanine rates of appearance (R(a); reflecting proteolysis) were measured across the leg (reflecting skeletal muscle) and in the whole body, utilizing a constant tracer infusion of [2H5]phenylalanine in the basal state and during euglycemic hyperinsulinemia (2,600 μU/ml) in seven normal adults. Phenylalanine R(a) in the leg was significantly decreased during hyperinsulinemia (6.11 ± 0.83 vs. 3.59 ± 0.70 μmol/min, P < 0.001). In contrast, leg phenylalanine rate of utilization (R(d)) was not significantly changed (4.88 ± 0.77 vs. 3.86 ± 0.92 μmol/min). Phenylalanine R(a) in the whole body was significantly decreased during hyperinsulinemia (49.4 ± 2.2 vs. 41.9 ± 2.3 μmol/min, P < 0.001). However, phenylalanine release was suppressed to a significantly greater degree in the leg than in the whole body during hyperinsulinemia (43 ± 7 vs. 15 ± 2{\%}, P < 0.01). These results suggest that insulin suppresses proteolysis in the whole body and in skeletal muscle, even in the face of hypoaminoacidemia. In addition, the substantially greater degree of suppression of proteolysis by insulin in skeletal muscle compared with the whole body suggests that, at least under these conditions, insulin may have a greater antiproteolytic effect on skeletal muscle compared with other tissues.",
keywords = "Insulin, Phenylalanine, Protein turnover, Stable isotope tracers",
author = "Scott Denne and Liechty, {E. A.} and Liu, {Y. M.} and G. Brechtel and Baron, {A. D.}",
year = "1991",
language = "English",
volume = "261",
journal = "American Journal of Physiology - Renal Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "6 24-6",

}

TY - JOUR

T1 - Proteolysis in skeletal muscle and whole body in response to euglycemic hyperinsulinemia in normal adults

AU - Denne, Scott

AU - Liechty, E. A.

AU - Liu, Y. M.

AU - Brechtel, G.

AU - Baron, A. D.

PY - 1991

Y1 - 1991

N2 - To simultaneously assess the relative antiproteolytic effect of insulin on both skeletal muscle and in the whole body, phenylalanine rates of appearance (R(a); reflecting proteolysis) were measured across the leg (reflecting skeletal muscle) and in the whole body, utilizing a constant tracer infusion of [2H5]phenylalanine in the basal state and during euglycemic hyperinsulinemia (2,600 μU/ml) in seven normal adults. Phenylalanine R(a) in the leg was significantly decreased during hyperinsulinemia (6.11 ± 0.83 vs. 3.59 ± 0.70 μmol/min, P < 0.001). In contrast, leg phenylalanine rate of utilization (R(d)) was not significantly changed (4.88 ± 0.77 vs. 3.86 ± 0.92 μmol/min). Phenylalanine R(a) in the whole body was significantly decreased during hyperinsulinemia (49.4 ± 2.2 vs. 41.9 ± 2.3 μmol/min, P < 0.001). However, phenylalanine release was suppressed to a significantly greater degree in the leg than in the whole body during hyperinsulinemia (43 ± 7 vs. 15 ± 2%, P < 0.01). These results suggest that insulin suppresses proteolysis in the whole body and in skeletal muscle, even in the face of hypoaminoacidemia. In addition, the substantially greater degree of suppression of proteolysis by insulin in skeletal muscle compared with the whole body suggests that, at least under these conditions, insulin may have a greater antiproteolytic effect on skeletal muscle compared with other tissues.

AB - To simultaneously assess the relative antiproteolytic effect of insulin on both skeletal muscle and in the whole body, phenylalanine rates of appearance (R(a); reflecting proteolysis) were measured across the leg (reflecting skeletal muscle) and in the whole body, utilizing a constant tracer infusion of [2H5]phenylalanine in the basal state and during euglycemic hyperinsulinemia (2,600 μU/ml) in seven normal adults. Phenylalanine R(a) in the leg was significantly decreased during hyperinsulinemia (6.11 ± 0.83 vs. 3.59 ± 0.70 μmol/min, P < 0.001). In contrast, leg phenylalanine rate of utilization (R(d)) was not significantly changed (4.88 ± 0.77 vs. 3.86 ± 0.92 μmol/min). Phenylalanine R(a) in the whole body was significantly decreased during hyperinsulinemia (49.4 ± 2.2 vs. 41.9 ± 2.3 μmol/min, P < 0.001). However, phenylalanine release was suppressed to a significantly greater degree in the leg than in the whole body during hyperinsulinemia (43 ± 7 vs. 15 ± 2%, P < 0.01). These results suggest that insulin suppresses proteolysis in the whole body and in skeletal muscle, even in the face of hypoaminoacidemia. In addition, the substantially greater degree of suppression of proteolysis by insulin in skeletal muscle compared with the whole body suggests that, at least under these conditions, insulin may have a greater antiproteolytic effect on skeletal muscle compared with other tissues.

KW - Insulin

KW - Phenylalanine

KW - Protein turnover

KW - Stable isotope tracers

UR - http://www.scopus.com/inward/record.url?scp=0026316130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026316130&partnerID=8YFLogxK

M3 - Article

VL - 261

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 1931-857X

IS - 6 24-6

ER -